FACTOR IX LEVELS DURING PREGNANCY IN A WOMAN WITH HEMOPHILIA BBRIET E; REISNER HM; BLATT PM et al.1982; HAEMOSTASIS; ISSN 0301-0147; CHE; DA. 1982; VOL. 11; NO 2; PP. 87-89; BIBL. 9 REF.Article

A ONE-YEAR FOLLOW-UP STUDY OF PLASMA FIBRINOPEPTIDE A AND BETA-THROMBOGLOBULIN AFTER DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISMVAN HULSTEIJN H; BERTINA R; BRIET E et al.1982; THROMB. RES.; ISSN 0049-3848; USA; DA. 1982; VOL. 27; NO 2; PP. 225-229; BIBL. 12 REF.Article

RENAL EMBOLISATION IN GLANZMANN'S THROMBASTHENIABRIET E; VISMANS FJ; VAN VOORTHUISEN AE et al.1980; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1980; VOL. 281; NO 6247; PP. 1039; BIBL. 4 REF.Article

Hip surgery in a patient with severe factor VII deficiencyBRIET, E; ONVLEE, G.Haemostasis. 1987, Vol 17, Num 5, pp 273-277, issn 0301-0147Article

MOLECULAR VARIANT OF FACTOR VII.BRIET E; LOELIGER EA; VAN TILBURG NH et al.1976; THROMBOSIS AND HAEMOSTASIS; GERM.; DA. 1976; VOL. 35; NO 2; PP. 289-294; ABS. FR. ALLEM.; BIBL. 20 REF.Article

AZATHIOPRINE AND SUBACUTE MYELOMONOCYTIC LEUKEMIAVISMANS JJ; BRIET E; MEIJER K et al.1980; ACTA MED. SCAND.; SWE; DA. 1980; VOL. 207; NO 4; PP. 315-319; BIBL. 27 REF.Article

DIAGNOSTIC VALUE OF FIBRINOPEPTIDE A AND BETA-THROMBOGLOBULIN IN ACUTE DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISMVAN HULSTEIJN H; BRIET E; KOCH C et al.1982; ACTA MED. SCAND.; ISSN 0001-6101; SWE; DA. 1982; VOL. 211; NO 5; PP. 323-330; BIBL. 24 REF.Article

CHRONIC LYMPHOCYTIC LEUKAEMIA AND IGG HEAVY CHAIN DISEASEBRIET E; VAN NIEUWKOOP JA; ZIJDE XMJ et al.1980; SCAND. J. HAEMATOL.; ISSN 0036-553X; DNK; DA. 1980; VOL. 25; NO 3; PP. 244-250; BIBL. 21 REF.Article

Hemophilia treatment in historical perspective : a review of medical and social developmentsROSENDAAL, F. R; SMIT, C; BRIET, E et al.Annals of hematology (Print). 1991, Vol 62, Num 1, pp 5-15, issn 0939-5555, 11 p.Article

USE OF ANTITHROMBIN CONCENTRATE IN STABLE DIFFUSE INTRAVASCULAR COAGULATIONHAAK HL; STOLK JC; GRATAMA JW et al.1982; ACTA HAEMATOL.; ISSN 0001-5792; CHE; DA. 1982; VOL. 68; NO 1; PP. 28-33; BIBL. 16 REF.Article

Coagulum pyelolithotomy: the determination of optimal conditions for clot formationLYCKLAMA, A. A. B; BRIET, E; JONAS, U et al.World journal of urology (Print). 1986, Vol 4, Num 2, pp 119-121, issn 0724-4983Article

Haemophilia B Leyden in GreeceMANDALAKI, T; LOUIZOU, C; DIMITRIADOU, C et al.Thrombosis and haemostasis. 1986, Vol 56, Num 3, pp 340-342, issn 0340-6245Article

The prophylactic treatment of hemophilia B Leyden with anabolic steroidsBRIET, E; WIJNANDS, M. C; VELTKAMP, J. J et al.Annals of internal medicine. 1985, Vol 103, Num 2, pp 225-226, issn 0003-4819Article

A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodiesGREEN, D; RADEMAKER, A. W; BRIËT, E et al.Thrombosis and haemostasis. 1993, Vol 70, Num 5, pp 753-757, issn 0340-6245Article

Double strand conformation polymorphism (DSCP) detects two point mutations at codon 280 (AAC→ATC) and at codon 431 (TAC→AAC) of the blood coagulation factor VIII genePIENEMAN, W. C; REITSMA, P. H; BRIËT, E et al.Thrombosis and haemostasis. 1993, Vol 69, Num 5, pp 473-475, issn 0340-6245Article

Inhibitors in hemophilia A : are some products safer ?BRIËT, E; ROSENDAAL, F. R.Seminars in hematology. 1994, Vol 31, Num 2, pp 11-15, issn 0037-1963, SUP4Conference Paper

John Hageman's factor and deep-vein thrombosis : Leiden thrombophilia studyKOSTER, T; ROSENDAAL, F. R; BRIET, E et al.British journal of haematology. 1994, Vol 87, Num 2, pp 422-424, issn 0007-1048Article

A congenitally abnormal fibronogen (vlissingen) with a 6-base deletion in the γ-chain gene, causing defective calcium binding and impaired fibrin polymerizationKOOPMAN, J; HAVERKATE, F; BRIET, E et al.The Journal of biological chemistry (Print). 1991, Vol 266, Num 20, pp 13456-13461, issn 0021-9258Article

An infrequent DNA polymorphism associated with severe von Willebrand's diseaseCAEKEBEKE-PEERLINCK, K. M. J; BAKKER, E; BRIET, E et al.British journal of haematology. 1990, Vol 75, Num 1, pp 78-81, issn 0007-1048, 4 p.Article

A randomized and blinded comparison of the sensitivity and the reproducibility of the Ivy and Simplate II^® bleeding time techniquesKOSTER, T; CAEKEBEKE-PEERLINCK, K. M. J; BRIET, E et al.American journal of clinical pathology. 1989, Vol 92, Num 3, pp 315-320, issn 0002-9173, 6 p.Article

Seeming homozygosity in type-IIB von Willebrand's disease due to a polymorphism within the sequence of a commonly used primerEIKENBOOM, J. C. J; REITSMA, P. H; BRIËT, E et al.Annals of hematology (Print). 1994, Vol 68, Num 3, pp 139-141, issn 0939-5555Article

A dutch pedigree with mild hemophilia B with a missense mutation in the first EGF domain (factor IX_{OudenNieuwGas}t_tel)POORT, S. R; BRIET, E; BERTINA, R. M et al.Nucleic acids research. 1989, Vol 17, Num 14, issn 0305-1048, 5869 [1 p.]Article

Noonan syndrome: partial factor XI deficiencyDE HAAN, M; VAN DER KAMP, J. J. P; BRIET, E et al.American journal of medical genetics. 1988, Vol 29, Num 2, pp 277-282, issn 0148-7299Article

Hemostasis and periventricular-intraventricular hemorrhage of the newbornVAN DE BOR, M; BRIET, E; VAN BEL, F et al.American journal of diseases of children (1960). 1986, Vol 140, Num 11, pp 1131-1134, issn 0002-922XArticle

Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (Hemophilia B Leyden phenotype)REITSMA, P. H; MANDALAKI, T; KASPER, C. K et al.Blood. 1989, Vol 73, Num 3, pp 743-746, issn 0006-4971Article